Regulation
Trade Associations Respond to Congressional Request for Information on CBD
The Council for Responsible Nutrition (CRN) and the Natural Products Association (NPA) have submitted responses to a Congressional Request for Information (RFI) seeking insight from industry stakeholders on CBD in order to develop “a regulatory pathway for non-intoxicating hemp-derived cannabinoid products that prioritizes consumer safety and provides certainty to the U.S. markets.” According to CRN, ...
NPA Issues Statement in Response to FDA’s Refusal to Hold Public Hearing Regarding NMN
On July 20, the U.S. Food and Drug Administration (FDA) rejected a request by Rep. Jeff Duncan (R-SC), a member of the House Energy and Commerce Committee, to hold a public hearing on the agency’s position on nicotinamide mononucleotide (NMN). FDA stated that a public comment period would be sufficient. In response, the Natural Products ...
Nammex Files Citizen Petition With FDA Over Mushroom Product Labeling
North American Reishi Ltd (Nammex), a Canada-based organic mushroom extract ingredient supplier, filed a citizen petition with the U.S. Food and Drug Administration (FDA). The petition, according to the company, requests that FDA addresses the mislabeling of dietary supplements and functional foods as “mushroom” or containing “mushrooms” when they do not, or fail to disclose ...
New FDA CBD Study is Disingenuous at Best, Harmful at Worst, Says NPA
On April 24, the Natural Products Association (NPA) responded to a study conducted by the Office of Food Additive Safety, Center for Food Safety and Applied Nutrition (CFSAN), reviewing the oral toxicity of cannabidiol (CBD). “Using drug standards to conduct a ‘supplement study’ is at the very least disingenuous and at the worst very harmful ...
NPA and ANH File Citizen’s Petition With FDA on Specific NMN Relief
The Natural Products Association (NPA) along with the Alliance for Natural Health (ANH) in a Citizen’s Petition to the Food and Drug Administration (FDA) requested the FDA: Determine nicotinamide mononucleotide (NMN) is not excluded from the definition of a dietary supplement under 21 U.S.C. §321(ff)(3)(B); Commit to exercising enforcement discretion in connection with the marketing ...
MPL for Dietary Supplements Omitted From Omnibus Spending Bill
The Omnibus Spending Bill was released on December 20 without including the controversial Mandatory Product Listing (MPL) of dietary supplements. Daniel Fabricant, PhD, president and CEO of the Natural Products Association (NPA), stated, “This is a big win for consumers, for innovation, and for access to the healthy products that millions of Americans rely on ...
Following Final NAC Guidance and Marketplace Stabilization, NPA Withdraws FDA Lawsuit
After securing final guidance for N-Acetyl-Cysteine (NAC) through a citizen petition and lawsuit, the Natural Products Association (NPA) dismissed its case against the U.S. Food and Drug Administration (FDA), which preserves legal rights and standing should additional action be necessary. The guidance also initiates the process for export certificates for NAC, which was a primary ...
Durbin, Braun Introduce Legislation to Mandate Product Listings for Dietary Supplements
U.S. Senate Majority Whip Dick Durbin (D-IL) and U.S. Senator Mike Braun (R-IN) introduced the Dietary Supplement Listing Act of 2022, bipartisan legislation to require dietary supplement manufacturers to list their products with the Food and Drug Administration (FDA). The Dietary Supplement Listing Act of 2022 would require companies to provide FDA with vital information about their products, ...
Congresswoman Pingree Unveils Hemp Bill
On Feb. 8, Congresswoman Chellie Pingree (D-Maine) introduced the Hemp Advancement Act of 2022 to improve the 2018 Farm Bill’s hemp provisions and provide greater clarity and flexibility to hemp growers and processors. While hemp production was federally legalized by the 2018 Farm Bill, red tape and regulatory uncertainty has hindered industry growth. “The 2018 Farm Bill laid a legal pathway for hemp ...
Frontline Segment: Skewed & Misleading, AHPA Says
A segment aired on January 19 on PBS’ Frontline presented dietary supplements as inherently unsafe by misrepresenting the rigorous safety provisions established for these products under the Federal Food, Drug and Cosmetics Act, the strict liability statute under which supplements are regulated. The segment, titled “Supplements and Safety,” relied on anecdotal reports of noncompliant products ...
Don't Miss Out!
Industry Professionals
Stay Informed!
Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Vitamin Retailer magazine and digital newsletter.
Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.
Featured Listing:
Subscribe To Our Newsletter
Stay Informed! Breaking news, industry trends featured topics, and more.
Subscribe to our newsletter today!